Genespire is a startup based in Germany, most recent round Series A, 1 tracked investor.
Genespire is a startup founded in 2020 based in Germany. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Genespire is a clinical-stage biotechnology company developing gene therapies for rare genetic diseases. Its lead program focuses on treating primary immunodeficiencies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.